Detalhe da pesquisa
1.
Factors related to the development of high antibody titres against SARS-CoV-2 in convalescent plasma donors from the ConPlas-19 trial.
Vox Sang
; 119(1): 27-33, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37986640
2.
Pathogen reduction with methylene blue does not have an impact on the clinical effectiveness of COVID-19 convalescent plasma.
Vox Sang
; 118(4): 296-300, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36734378
3.
Elranatamab treatment in a multiple myeloma patient undergoing renal dialysis.
Clin Hematol Int
; 6(2): 46-50, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38817306
4.
A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia.
J Clin Invest
; 131(20)2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34473652